Immutep selects Charles River to conduct toxicology study for IMP761
Immutep has selected Charles River Laboratories to conduct a Good Laboratory Practice (GLP) toxicology study of its proprietary preclinical candidate…
Immutep has selected Charles River Laboratories to conduct a Good Laboratory Practice (GLP) toxicology study of its proprietary preclinical candidate…
Telemedicine remains the leading decentralisation approach in clinical trials in Q2 of this year. The continued rise of telemedicine as…
The oncology space is one of the largest hotbeds for drug development and innovation, and in the past few decades,…